AstraZeneca's Soriot is considering move of stock listing to the US: Times
2nd July 2025 Uncategorised 0AstraZeneca CEO Pascal Soriot is plotting a shift of the company’s primary stock listing from the London to the U.S., according to The Times. In the report, the British news outlet cites multiple unnamed sources, including one who added that Soriot has even discussed basing AZ’s business in the U.S.
More: AstraZeneca's Soriot is considering move of stock listing to the US: Times
Source: fierce